Reovirus may be a novel approach to prostate cancer treatment
Wednesday, March 10th, 2010 Posted in prostate cancer | No Comments »According to study results, Canadian researchers have detected a novel oncolytic viral therapy against prostate cancer with use of a virus called the reovirus. The respiratory, enteric, orphan virus (commonly known as reovirus) is a non-attenuated, environmental virus that has shown ...
New class of agents in the treatment of prostate cancer.
Tuesday, March 2nd, 2010 Posted in prostate cancer | No Comments »A scientific team proposes the potential of a whole new class of agents in the treatment of prostate cancer. Researchers have reported data suggesting that some selective estrogen receptor-? (ER?) agonists may have efficacy in the treatment of prostate cancer - ...
Helping prostate cancer patients with localized disease reach treatment decisions
Sunday, February 28th, 2010 Posted in prostate cancer | No Comments »A recent sudy at Tom Baker Cancer Center, Psychosocial Resources, 2202 2nd St SW, Calgary, Canada, aimed to highlight two important aspects: role of psychosocial variables in treatment decision making for patients with localized prostate cancer, and how family physicians can be ...
Patient misperceptions about treatment choices for localized prostate cancer
Saturday, February 27th, 2010 Posted in prostate cancer | No Comments »Researchers at Eastern Virginia Medical School, USA, suggest that higher education, income and functional capacity of cancer patients are associated with poorer knowledge about their cancer, poorer understanding about treatment choices, and poorer judgement about survival with and without treatment ...
Focal therapy may be the future for prostate cancer
Thursday, February 25th, 2010 Posted in prostate cancer | No Comments »A scientific team at University College London, UK, has now published an article outlining the need for an international research strategy which could be used to evaluate focal therapy over time. According to which should be "pragmatic" in nature and ...
Statins may benefit prostate cancer patients
Wednesday, February 24th, 2010 Posted in prostate cancer | No Comments »Duke University Medical Center researchers found cholesterol-lowering statins significantly reduce prostate tumor inflammation. This new study suggests this finding may help lower the risk of disease progression Researchers concluded that the use of statins before prostate cancer surgery was associated with ...
Effect of extended vs standard pelvic lymphadenectomy
Saturday, February 20th, 2010 Posted in prostate cancer | No Comments »A recent study at The Royal Surrey County Hospital, Guildford, UK, investigated the effect of extended vs standard pelvic lymphadenectomy (sPLND) for patients with intermediate- and high-risk prostate cancer undergoing laparoscopic radical prostatectomy (LRP). Study team has published data from their ...
Abiraterone drug shows promise for advanced prostate cancer
Friday, February 19th, 2010 Posted in prostate cancer | No Comments »Recent results related to a phase II clinical trial of the prostate cancer drug abiraterone confirm that it may help men with advanced disease who have tried standard treatments. According to research team, new drug shows promise for advanced prostate cancer ...
Continued costs of prostate cancer treatment are not sustainable
Wednesday, February 17th, 2010 Posted in prostate cancer | No Comments »Two recent studies have examined the increasing economic burden of prostate cancer — in the USA and in selected European nations. The picture is not a pretty one. The American study conducted a retrospective analysis of medical and pharmacy claims between ...
Genetic test that can distinguish between aggressive prostate cancers slow-growing tumors
Monday, February 15th, 2010 Posted in prostate cancer | No Comments »Harvard researchers showed in a model that when you take a gene out, you get metastasis and when you put it back in you don't get metastasis. Based on this conclusion, they report what they say is a major advance ...